Top European IT Services & Payments Stocks, According to BofA

Bank of America reiterated Buy ratings across 8 European IT Services & Payments names while lifting/maintaining key growth expectations tied to digital transformation and cross-border payments. Notable calls include Capgemini with fiscal 2026 organic growth forecast raised to 4.0% (vs 3.1% prior) and €1.8B organic free cash flow, Netcompany with a price objective at DKK 417 (+33% upside), and Adyen projecting 20.9% 2026 revenue growth excluding M&A. Overall, the note is constructive for the sector as multiple targets were raised (e.g., Computacenter target to 6,014p implying 19% upside; Sabre to $2.6 from $2.3) on stronger/raised fundamentals and rerating after Q2 results.

Analysis

The market is likely to treat this as a quality/growth rerating signal, but the real edge is relative duration. The names with visible free-cash-flow inflection and premium software-like economics should keep outperforming on any dip, while lower-multiple legacy software and travel-distribution plays can only keep up if they show evidence that pricing power and mix are improving. In other words, this is less about “Europe IT” and more about which businesses can sustain 20%+ compounding without needing macro help.

Second-order, the strongest competitive pressure is on smaller payment and remittance rails: when a scaled platform wins wallet share, it often forces incumbents to spend more on compliance, fraud, and customer acquisition just to defend volume. That creates a widening gap between platform leaders and everyone else, but it also raises the bar for the leaders — if growth slows even modestly, their multiples can compress faster than earnings can grow. For the travel-tech name, any re-rating is fragile because the equity story still depends on a cyclical booking recovery and industry share gains that can reverse quickly if airline capacity or corporate travel softens.

Contrarian view: this may be a crowded factor trade disguised as stock picking. European real yields, FX, and PMI trends matter more than the analyst tone here; if those go against the group, the valuation support can vanish before the medium-term FCF story becomes visible. Near term, expect a tactical pop; over 1-3 months the key test is whether the next prints convert optimistic forecasts into actual organic growth and margin expansion. The thesis is falsified if rates back up materially or if the next earnings/guidance cycle shows slower-than-modeled take-rate, bookings, or public-sector conversion.

Key Decisions for Investors

• Buy ADYEY and CGEMY on post-note weakness rather than chasing the open; use a 1-3 month horizon with a ~10-15% upside target and cut if the next print fails to confirm organic growth acceleration or FCF conversion.
• Pair trade: long ADYEY / short SABR for a quality-growth vs cyclical-distribution expression; risk/reward favors the long leg if rates stay stable, but cover if Sabre’s next update shows durable NDC-driven share gains.
• Initiate a small tactical long in WIZEY only on pullbacks; the stock should work if cross-border volumes stay resilient, but the position should be sized for a quick stop if growth decelerates or regulatory/compliance expense steps up.
• Use NTCYF as a higher-beta satellite long, not a core position; the upside is tied to public-sector digitization, but procurement timing can shift revenue by quarters, so treat any entry as a 6-12 month hold with patience for lumpy execution.
• Avoid adding exposure to SABR ahead of its next catalyst unless booking trends are clearly inflecting; the name has more downside if the market decides the rerating is premature and earnings leverage is less durable than expected.